版本:
中国

BRIEF-Cidara Therapeutics selects first development candidate from its Cloudbreak Immunotherapy Discovery Platform

Sept 21 Cidara Therapeutics Inc

* Cidara Therapeutics selects first development candidate from its CloudbreakTM immunotherapy discovery platform

* Expect to file an ind next year to initiate clinical development of CD201. Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐